Congenital clubfoot in Europe: A population-based study.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
04 2019
Historique:
received: 07 09 2018
revised: 13 01 2019
accepted: 17 01 2019
pubmed: 12 2 2019
medline: 23 4 2020
entrez: 12 2 2019
Statut: ppublish

Résumé

We aimed to assess prevalence, birth outcome, associated anomalies and prenatal diagnosis of congenital clubfoot in Europe using data from the EUROCAT network, and to validate the recording of congenital clubfoot as a major congenital anomaly by EUROCAT registries. Cases of congenital clubfoot were included from 18 EUROCAT registries covering more than 4.8 million births in 1995-2011. Cases without chromosomal anomalies born during 2005-2009, were randomly selected for validation using a questionnaire on diagnostic details and treatment. There was 5,458 congenital clubfoot cases of which 5,056 (93%) were liveborn infants. Total prevalence of congenital clubfoot was 1.13 per 1,000 births (95% CI 1.10-1.16). Prevalence of congenital clubfoot without chromosomal anomaly was 1.08 per 1,000 births (95% CI 1.05-1.11) and prevalence of isolated congenital clubfoot was 0.92 per 1,000 births (95% CI 0.90-0.95), both with decreasing trends over time and large variations in prevalence by registry. The majority of cases were isolated congenital clubfoot (82%) and 11% had associated major congenital anomalies. Prenatal detection rate of isolated congenital clubfoot was 22% and increased over time. Among 301 validated congenital clubfoot cases, diagnosis was confirmed for 286 (95%). In conclusion, this large population-based study found a decreasing trend of congenital clubfoot in Europe after 1999-2002, an increasing prenatal detection rate, and a high standard of coding of congenital clubfoot in EUROCAT.

Identifiants

pubmed: 30740879
doi: 10.1002/ajmg.a.61067
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

595-601

Subventions

Organisme : European Commission under the Seventh Framework Programme through the key action
ID : HEALTH.2010.4.2 -3
Pays : International
Organisme : Adverse Drug Reaction Research
ID : 260598
Pays : International
Organisme : GlaxoSmithKline, 2007-2011 for staff time (Universities of Groningen and Ulster)
Pays : International
Organisme : Adverse Drug Reaction Research
ID : no. 260598
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Hao Wang (H)

Department of PharmacoTherapy, Epidemiology and Economics (PTEE) / Division: Groninger Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, Belfast, UK.

Ingeborg Barisic (I)

Department of Medical Genetics and Reproductive Health, Children's Hospital Zagreb, Medical School University of Zagreb, Zagreb, Croatia.

Maria Loane (M)

Institute of Nursing & Health Research, Ulster University, Northern Ireland.

Marie-Claude Addor (MC)

Department of Woman-Mother-Child, University Hospital Center CHUV, Lausanne, Switzerland.

Linda M Bailey (LM)

Congenital Anomaly Register and Information Service for Wales, Public Health UK NHS Trust, Swansea, Wales, UK.

Miriam Gatt (M)

Directorate for Health Information and Research, Tal-Pietà, Malta.

Kari Klungsoyr (K)

Division of Mental and Physical Health, Norwegian Institute of Public Health and Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

Olatz Mokoroa (O)

Malta Congenital Anomalies Register, Directorate for Health Information and Research, G'Mangia, Malta.

Vera Nelen (V)

Province of Antwerp Department of Environment, Provincial Institute of Hygiene, Antwerp, Belgium.

Amanda J Neville (AJ)

IMER Registry, Center for Clinical and Epidemiological Research, University of Ferrara and Azienda Ospedaliero Universitario di Ferrara, Ferrara, Italy.

Mary O'Mahony (M)

Department of Public Health, Health Service Executive - South, Ireland.

Anna Pierini (A)

Tuscany Registry of Congenital Defects, Institute of Clinical Physiology-National Research Council/Fondazione Toscana "Gabriele Monasterio", Pisa, Italy.

Anke Rissmann (A)

Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Christine Verellen-Dumoulin (C)

Center for Human Genetics, Institut de Pathologie et de Génétique, Charleroi, Belgium.

Hermien E K de Walle (HEK)

Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.

Awi Wiesel (A)

Department of Pediatrics, Birth Registry Mainz Model, University Medical Center of Mainz, Mainz, Germany.

Katarzyna Wisniewska (K)

Department of Preventive Medicine, Epidemiology Unit, Poznan University of Medical Sciences, Poznan, Poland.

Lolkje T W de Jong-van den Berg (LTW)

Department of PharmacoTherapy, Epidemiology and Economics (PTEE) / Division: Groninger Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, Belfast, UK.

Helen Dolk (H)

Institute of Nursing & Health Research, Ulster University, Northern Ireland.

Babak Khoshnood (B)

INSERM UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Center of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), DHU Risks in Pregnancy, Paris Descartes University, Paris, France.

Ester Garne (E)

Paediatric Department, Hospital Lillebaelt Kolding, Kolding, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH